Announced May 5, 2022, the FDA has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 vaccine because they would otherwise not receive a COVID-19 vaccine.
See EUA Fact Sheet for Healthcare Providers Administering Vaccine .
Resources
FDA’s J&J EUA aligns with recommendations from the CDC's Advisory Committee in Immunization Practices (ACIP). Please see the following helpful resources:
Thank you,
Immunization Service | Oklahoma State Department of Health
|
